semaglutide and sickness Philly lab reveals how obesity drugs like Ozempic cause nausea Managing Nausea From Semaglutide &

fast 20262029 pipeline snapshot: Novo Nordisk CagriSema (GLP-1 + amylin) Filing 2026 Lilly Orforglipron (oral GLP-1) + Retatrutide (triple agonist) Launch window 20262027 Amgen Maritide (GLP-1 + GIP) 20272028 target BI / Zealand Survodutide (GLP-1 + glucagon) 2027 Altimmune Pemvidutide (GLP-1 + glucagon) 2027 Roche CT-388 / Petrelintide possible 2029 And one notable miss: Pfizer Danuglipron discontinued Clear trend: Single GLP-1 dual triple agonists Competition is shifting from: Who has a GLP-1? to Who has the most effective combination biology? Execution risk is still real but the bar for efficacy is moving quickly

Maintain hydration, especially if appetite is reduced

Appetite drops, nausea rises, and normal meals suddenly feel like too much

Instead of asking: How do I burn more calories? GLP-1 answers a different question: How should the body respond to this meal? That shift changes everything

May your gut health stay balanced, your metabolic pathways stay optimized, and your supplement decisions stay informed.

Florut, T.F